NESICHNCT05539859
Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage
StatusRecruiting
PhaseNot applicable
SponsorSouthwest Hospital, China
Primary completion (estimated)
At risk: Primary completion moved at least 2 years 9 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Sep 1, 2025 to Jun 30, 2028 Show 6 more changesShow less
- Eligibility criteria expanded, about 16 words
- Trial status changed: Unknown → Recruiting
- Study completion pushed from Sep 1, 2026 to Dec 31, 2028
- Secondary endpoints: details revised at 11 of 16 entries
- Site details revised at 2 of 4 sites
- Publications: details revised at 7 of 7 entries
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Notable Eligibility criteria shortened, about 287 words
- Trial status: Recruiting to Unknown
- Secondary endpoints: 17 to 16
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 4
- Start date changed from estimate of Oct 1, 2022 to Nov 18, 2022
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
The proportion of patients with Modified Rankin Scale (mRS) score 0-3
Timeframe: 180 days
Safety outcome
Timeframe: 180 days
Secondary (8)
Glasgow Outcome Scale Extended (GOS-E)
Modified Rankin Scale (mRS) Score
Survival rate
Assessment of cognitive function with Mini-Mental State Examination (MMSE)
Quality of life measured with the 5-level EQ-5D (EQ-5D-5L)
Show 3 moreShow less
Length of ICU
Length of hospitalization
In-hospital cost
Arms and interventions
Experimental ArmExperimental
Endoscopic surgery
Control ArmActive comparator
Medical management
Procedures: Endoscopic surgery
Other: Medical management
Sites
4 sites in 1 country